U-Neuron Biomedical, Inc. engages in the research and development of stem cell storage and separation technology, and treatment application technology. It focuses in the study of Amniotic Fluid Stem Cells, Olfactory Stem Cells, and Adipose-derived Stem Cells. The company was founded on September 4, 2015 and is headquartered in New Taipei, Taiwan.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company